As a health sector investor, you will be aware of the quality and compliance environment your developer is working in; but how much have you invested in managing the risk?

Most investments are driven by the search for novel medicines or devices to improve human health, and deliver a healthy financial return for these potentially risky ventures. An effective Quality Management System (QMS) is not normally your priority, and a fully functioning QMS is unrealistic in the normal timescales to achieve your early development milestones. The impact of a quality or compliance failure can be catastrophic for your programme, causing significant time delays or stopping the development of a potentially effective product.

It’sQA is an expert in QMS, with methodologies that will enable your investment to be protected from month 1, and grow with the demands and volume of your programme. We will ensure that your programme and clinical trials are inspection ready, allowing your key scientific and research staff to focus on what they do best. This scaling process will enable you to manage your quality investment effectively, ensuring you are in control.